Selected article for: "pre existing immunity and seroconversion pre existing immunity"

Author: Bingyi Yang; Justin Lessler; Huachen Zhu; Chaoqiang Jiang; Jonathan M. Read; James A Hay; Kin On Kwok; Ruiyin Shen; Yi Guan; Steven Riley; Derek A.T. Cummings
Title: Life course exposures continually shape antibody profile and risk of seroconversion to influenza
  • Document date: 2020_1_16
  • ID: cyxn7dpw_121
    Snippet: We included serum from all participants regardless of their vaccination status in the main analysis and used serum from participants who self-reported no previous vaccination against influenza in both visits in the sensitivity analysis (table S18), in particular summary metrics metrics of antibody profiles and effects of pre-existing immunity on seroconversion to recent strains. Age patterns in summary metrics of antibody profiles of those unvacc.....
    Document: We included serum from all participants regardless of their vaccination status in the main analysis and used serum from participants who self-reported no previous vaccination against influenza in both visits in the sensitivity analysis (table S18), in particular summary metrics metrics of antibody profiles and effects of pre-existing immunity on seroconversion to recent strains. Age patterns in summary metrics of antibody profiles of those unvaccinated participants (fig. S10) were similar to results including all participants ( Fig. 2 and fig. S3 ). Vaccination status . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antibody profile and cc NC International license: 1
    • antibody profile and International license: 1
    • antibody profile and pre existing immunity: 1, 2, 3, 4
    • antibody profile and sensitivity analysis: 1
    • cc NC International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC International license and main analysis: 1
    • cc NC International license and pre existing immunity: 1, 2, 3
    • cc NC International license and recent strain: 1
    • cc NC International license and recent strain seroconversion: 1
    • cc NC International license and sensitivity analysis: 1, 2, 3, 4, 5, 6, 7, 8
    • influenza previous vaccination and pre existing immunity: 1
    • influenza previous vaccination and pre existing immunity effect: 1
    • influenza previous vaccination and previous vaccination: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza previous vaccination and vaccination status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • International license and main analysis: 1
    • International license and pre existing immunity: 1, 2, 3
    • International license and recent strain: 1
    • International license and recent strain seroconversion: 1
    • International license and sensitivity analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13